Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice.
Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice.
复制标题
脑癌敲除小鼠中脑出血后纹状体损伤和行为缺陷增加。
DOI:
10.3171/2010.10.jns10861
复制
发表时间:
2011-04
影响因子:
4.1
通讯作者:
Regan RF
中科院分区:
文献类型:
--
作者:
Chen L;Zhang X;Chen-Roetling J;Regan RF
Heme toxicity may contribute to the pathogenesis of intracerebral hemorrhage. The primary defense against extracellular heme is provided by hemopexin, a serum and neuronal glycoprotein that binds it with very high affinity and mitigates its pro-oxidant effect. In the present study, we tested the hypothesis that hemopexin knockout mice would sustain more injury after experimental intracerebral hemorrhage than their wild-type counterparts. Striatal intracerebral hemorrhage was induced by stereotactic injection of bacterial collagenase or autologous blood. Three days later, striatal protein oxidation was assessed by carbonyl assay. Cell viability was quantified at 8-9 days using the methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay. Behavioral deficits were detected by high resolution digital analysis of six hour home cage video recordings and standard testing. Perihematomal protein oxidation was increased in wild-type collagenase-injected striata by approximately 2.1-fold compared with contralateral striata vs. 3-fold in knockouts. Striatal cell viability was reduced in wild-type mice to 52.9±6.5% of that in contralateral striata by collagenase injection, and to 31.1%±3.7% in knockouts; similar results were obtained after blood injection. Digital analysis of home cage video recordings demonstrated an activity deficit in both models that was significantly exacerbated at 8 days in knockouts. Striatal heme content 9 days after blood injection was increased approximately 2.7-fold by hemopexin knockout. These results suggest that hemopexin has a protective effect against hemorrhagic CNS injuries. Hemopexin deficiency, which is often associated with sickle cell disease, may worsen outcome after intracerebral hemorrhage.